Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Asian Stocks Down as Resurgent COVID-19 Cases Threaten Global Economic Recovery

Published 04/20/2021, 11:42 PM
Updated 04/20/2021, 11:53 PM
© Reuters.

By Gina Lee

Investing.com – Asia Pacific stocks were down Wednesday morning, following in U.S. shares’ footsteps as COVID-19 cases continue to resurge globally and overshadowing recent solid corporate earnings.

Japan’s Nikkei 225 slid 2.07% by 10:59 PM ET (2:59 AM GMT) with Tokyo and Osaka reportedly due to ask that a state of emergency be declared in the country’s two biggest cities.

South Korea’s KOSPI fell 1.50% and in Australia, the ASX 200 was down 1.39%.

Hong Kong’s Hang Seng Index fell 1.67%.

China’s Shanghai Composite inched down 0.10% and the Shenzhen Component was down 0.39%.

Shares in International Business Machines Corp. (NYSE:IBM) climbed after the company reported its largest revenue growth in 11 quarters earlier in the week. However, United Airlines Holdings Inc. (NASDAQ:UAL) reported a bigger-than-expected loss and Netflix Inc. (NASDAQ:NFLX) shares also fell in post-market trading after its first-quarter subscriber growth fell short of the average analyst estimate.

Global shares came under pressure after climbing to record highs after rising COVID-19 cases globally introduced the possibility of fresh restrictive measures, threatening the already-fragile economic recovery. The number of COVID-19 cases globally surpassed the 142.5-million mark as of Apr. 21, according to Johns Hopkins University data.

Slower-than-expected COVID-19 vaccine uptake numbers and concerns about side effects have also hampered the global economic recovery after positive uptake numbers were recently reported in the U.S., U.K. and Europe.

U.S. health agencies recommended pausing the usage of Johnson & Johnson's (NYSE:JNJ) single-shot vaccine during the previous week as potential side effects are investigated. While the U.S. Centers for Disease Control and Prevention is due to reach a decision about the vaccine on Friday, the European Medicines Agency said on Tuesday that it would resume use of the jab.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

“The data is very mixed: on the positive side we have great vaccine rollouts that are happening and then the negative is that we have the J&J vaccine being halted,” Kayne Anderson Rudnick portfolio manager Julie Biel told Bloomberg.

“Is that going to create more vaccine hesitancy? How much of that is going to impact longer-term the ability to reopen?” The end of the pandemic “is going to be much more of a push-pull, it’s going to happen in increments,” Biel added.

Meanwhile, Treasuries held a rally that sent the benchmark 10-year yield to its lowest level in more than five weeks. The European Central Bank will also hand down its policy decision on Thursday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.